Taysha Gene Therapies, Inc. (TSHA) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,842
Total Return
-81.58%
CAGR
-28.71%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.60% |
| Median | -5.30% |
| Best | +426.85% |
| Worst | -54.35% |
| % of Windows Positive | 38.4% |
1-Year (252 Trading Days)
| Average | +25.12% |
| Median | -16.00% |
| Best | +440.13% |
| Worst | -92.12% |
| % of Windows Positive | 44.4% |
3-Year (756 Trading Days)
| Average | +13.33% |
| Median | -69.76% |
| Best | +613.19% |
| Worst | -92.37% |
| % of Windows Positive | 30.9% |
Risk Metrics
| Maximum Drawdown | -97.76% |
| Average Drawdown | -80.18% |
| Drawdown Duration | 1204 Trading Days (Unrecovered) |
| Sortino Ratio | 0.54 |
| Calmar Ratio | -0.29 |
| CVaR (5%) | -12.40% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -14.36% (-41.99% ann.) | $1436.34 | $0.00 | $0.00 | $0.00 |
| 2025 | +217.92% | +$21791.69 | $0.00 | $0.00 | $0.00 |
| 2024 | -2.26% | $225.92 | $0.00 | $0.00 | $0.00 |
| 2023 | -21.68% | $2168.16 | $0.00 | $0.00 | $0.00 |
| 2022 | -80.60% | $8060.08 | $0.00 | $0.00 | $0.00 |
| 2021 | -56.10% | $5610.40 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +10.31% (+44.14% ann.) | +$1030.76 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | September 24, 2020 – November 6, 2020 | -14.80% | -74.34% | $1479.63 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -39.06% | -37.49% | $3905.64 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -85.44% | -87.07% | $8543.91 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +11.80% | +6.20% | +$1179.56 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +119.07% | +64.85% | +$11907.01 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.